name,category,termsBTB and CNC homology 1, basic leucine zipper transcription factor 2,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010229$IPR011333:BTB/POZ fold, 450010446$IPR011616:bZIP transcription factor, bZIP-1, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related]
BTB and CNC homology 1, basic leucine zipper transcription factor 2,OMIM_DISEASE[520001922$Follow up analysis of genome-wide association data identifies novel loci for type 1 diabetes, 520003249$Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci]
BTB and CNC homology 1, basic leucine zipper transcription factor 2,SMART[760000197$SM00225:BTB, 760000306$SM00338:BRLZ]
BTB and CNC homology 1, basic leucine zipper transcription factor 2,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
BTB and CNC homology 1, basic leucine zipper transcription factor 2,UP_SEQ_FEATURE[850065470$chain:Transcription regulator protein BACH2, 850102572$compositionally biased region:Poly-Glu, 850102900$DNA-binding region:Basic motif, 850103177$domain:BTB, 850104712$domain:Leucine-zipper, 850117294$sequence conflict, 850117295$sequence variant]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),INTERPRO[450008710$IPR009617:Adipose-regulatory protein, Seipin]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),OMIM_DISEASE[520002905$Lipodystrophy, congenital generalized, type 2, 520003610$Neuropathy, distal hereditary motor, type V, 520004483$Silver spastic paraplegia syndrome, 520004539$Spastic paraplegia 17 (autosomal dominant), 520004540$spastic paraplegia 17 (Silver syndrome), 520004549$Spastic paraplegia with amyotrophy of hands and feet (Silver syndrome), 520004595$Spinal muscular atrophy, distal, type V]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000362$congenital generalized lipodystrophy, 790000430$diabetes mellitus, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000675$hereditary spastic paraplegia, 790000919$membrane, 790001015$neurodegeneration, 790001555$transmembrane]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),UP_SEQ_FEATURE[850059230$chain:Seipin, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
G protein-coupled receptor 156,INTERPRO[450002178$IPR002455:GPCR, family 3, gamma-aminobutyric acid receptor, type B, 450016286$IPR017978:GPCR, family 3, C-terminal, 450016287$IPR017979:GPCR, family 3, conserved site, 450018025$IPR019793:Peroxidases heam-ligand binding site]
G protein-coupled receptor 156,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
G protein-coupled receptor 156,PIR_SUPERFAMILY[630030195$PIRSF038693:probable G protein-coupled receptor 156]
G protein-coupled receptor 156,SP_PIR_KEYWORDS[790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 156,UP_SEQ_FEATURE[850042052$chain:Probable G-protein coupled receptor 156, 850102566$compositionally biased region:Poly-Arg, 850102581$compositionally biased region:Poly-Ser, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
InaD-like (Drosophila),INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF, 450003682$IPR004172:L27, 450013579$IPR015132:L27-2]
InaD-like (Drosophila),KEGG_PATHWAY[470038857$hsa04530:Tight junction]
InaD-like (Drosophila),SMART[760000200$SM00228:PDZ, 760000506$SM00569:L27]
InaD-like (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001528$Tight junction]
InaD-like (Drosophila),UP_SEQ_FEATURE[850025701$chain:InaD-like protein, 850104597$domain:L27, 850104919$domain:PDZ 1, 850104920$domain:PDZ 10, 850104924$domain:PDZ 2, 850104925$domain:PDZ 3, 850104926$domain:PDZ 4, 850104927$domain:PDZ 5, 850104928$domain:PDZ 6, 850104929$domain:PDZ 7, 850104930$domain:PDZ 8, 850104931$domain:PDZ 9, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2,INTERPRO[450007116$IPR007763:NADH:ubiquinone oxidoreductase, 17.2 kD subunit]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2,OMIM_DISEASE[520003336$Mitochondrial complex I deficiency]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2,SP_PIR_KEYWORDS[790000288$Chaperone, 790000356$complete proteome, 790000969$mitochondrion, 790001550$transit peptide]
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2,UP_SEQ_FEATURE[850031740$chain:Mimitin, mitochondrial, 850118617$transit peptide:Mitochondrion]
adenosine monophosphate deaminase (isoform E),INTERPRO[450001209$IPR001365:Adenosine/AMP deaminase, 450005754$IPR006329:AMP deaminase, 450006065$IPR006650:Adenosine/AMP deaminase active site, 450014621$IPR016297:AMP deaminase, metazoa]
adenosine monophosphate deaminase (isoform E),KEGG_PATHWAY[470038742$hsa00230:Purine metabolism]
adenosine monophosphate deaminase (isoform E),OMIM_DISEASE[520000266$AMP deaminase deficiency, erythrocytic]
adenosine monophosphate deaminase (isoform E),PIR_SUPERFAMILY[630001397$PIRSF001251:AMP_deaminase_met]
adenosine monophosphate deaminase (isoform E),SP_PIR_KEYWORDS[790000051$alternative initiators, 790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000512$erythrocyte, 790000743$hydrolase, 790001062$nucleotide metabolism, 790001162$phosphoprotein, 790001212$polymorphism]
adenosine monophosphate deaminase (isoform E),UP_SEQ_FEATURE[850005143$chain:AMP deaminase 3, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
apoptosis, caspase activation inhibitor,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
apoptosis, caspase activation inhibitor,UP_SEQ_FEATURE[850010295$chain:Cell death regulator Aven, 850102390$compositionally biased region:Ala/Gly-rich, 850106258$modified residue, 850117295$sequence variant]
atrophin 1,INTERPRO[450002600$IPR002951:Atrophin-like, 450016301$IPR017993:Atrophin-1]
atrophin 1,OMIM_DISEASE[520001452$Dentatorubro-pallidoluysian atrophy]
atrophin 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000509$epilepsy, 790001015$neurodegeneration, 790001162$phosphoprotein, 790001212$polymorphism, 790001569$triplet repeat expansion]
atrophin 1,UP_SEQ_FEATURE[850006808$chain:Atrophin-1, 850102379$compositionally biased region:Ala/Arg-rich, 850102416$compositionally biased region:Arg/Glu-rich (mixed charge), 850102516$compositionally biased region:Glu/Ser-rich, 850102570$compositionally biased region:Poly-Gln, 850102574$compositionally biased region:Poly-His, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
calcium/calmodulin-dependent protein kinase II gamma,BIOCARTA[30000039$h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway, 30000043$h_CaCaMPathway:Ca++/ Calmodulin-dependent Protein Kinase Activation, 30000070$h_crebPathway:Transcription factor CREB and its extracellular signals, 30000226$h_pgc1aPathway:Regulation of PGC-1a, 30000279$h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents]
calcium/calmodulin-dependent protein kinase II gamma,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450012167$IPR013543:Calcium/calmodulin dependent protein kinase II, association-domain, 450014177$IPR015742:Calcium/calmodulin-dependent protein kinase II isoform, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
calcium/calmodulin-dependent protein kinase II gamma,KEGG_PATHWAY[470038828$hsa04012:ErbB signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038835$hsa04114:Oocyte meiosis, 470038846$hsa04310:Wnt signaling pathway, 470038876$hsa04720:Long-term potentiation, 470038877$hsa04722:Neurotrophin signaling pathway, 470038879$hsa04740:Olfactory transduction, 470038883$hsa04912:GnRH signaling pathway, 470038885$hsa04916:Melanogenesis, 470038904$hsa05214:Glioma]
calcium/calmodulin-dependent protein kinase II gamma,PIR_SUPERFAMILY[630000701$PIRSF000594:calcium/calmodulin-dependent protein kinase II]
calcium/calmodulin-dependent protein kinase II gamma,SMART[760000193$SM00220:S_TKc]
calcium/calmodulin-dependent protein kinase II gamma,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000218$calmodulin-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
calcium/calmodulin-dependent protein kinase II gamma,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009093$chain:Calcium/calmodulin-dependent protein kinase type II subunit gamma, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850111164$region of interest:Calmodulin-binding, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
cerebral cavernous malformation 2,INTERPRO[450005462$IPR006020:Phosphotyrosine interaction region]
cerebral cavernous malformation 2,OMIM_DISEASE[520000906$Cerebral cavernous malformations-2]
cerebral cavernous malformation 2,SMART[760000407$SM00462:PTB]
cerebral cavernous malformation 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790001162$phosphoprotein, 790001212$polymorphism]
cerebral cavernous malformation 2,UP_SEQ_FEATURE[850030266$chain:Malcavernin, 850104993$domain:PID, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 20 open reading frame 132,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 20 open reading frame 132,UP_SEQ_FEATURE[850073700$chain:Uncharacterized protein C20orf132, 850117294$sequence conflict, 850118574$splice variant]
dishevelled associated activator of morphogenesis 1,INTERPRO[450002728$IPR003104:Actin-binding FH2 and DRF autoregulatory, 450009531$IPR010472:Diaphanous FH3, 450009532$IPR010473:Diaphanous GTPase-binding, 450013217$IPR014767:Diaphanous autoregulatory, 450013218$IPR014768:GTPase-binding/formin homology 3, 450013867$IPR015425:Actin-binding FH2]
dishevelled associated activator of morphogenesis 1,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway]
dishevelled associated activator of morphogenesis 1,SMART[760000441$SM00498:FH2]
dishevelled associated activator of morphogenesis 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000019$actin-binding, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm]
dishevelled associated activator of morphogenesis 1,UP_SEQ_FEATURE[850015283$chain:Disheveled-associated activator of morphogenesis 1, 850102586$compositionally biased region:Pro-rich, 850103478$domain:DAD, 850103773$domain:FH1, 850103774$domain:FH2, 850104044$domain:GBD/FH3, 850105852$helix, 850106259$mutagenesis site, 850110834$region of interest:Actin-binding, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
